# Turquoise Module Run: Discovery Output (107-analyte, dev, 2026-06-23)

This document presents the discovery output of a full-module run of the **Turquoise** WGCNA module through the Kraken 12-node discovery pipeline, executed on the dev environment on 2026-06-23 (commit `813fc3f`) with BioMapper entity resolution enabled. It is one of a per-module series over the Frailty multi-omics WGCNA modules; see the [BioMapper: Collection Index](https://phwiki.phenoma.ai/doc/biomapper-collection-index-UcTfYSTchm).

## Run Provenance

The run submitted 107 named analytes, parsed 106 at intake, and resolved 106 distinct entities (99 biomapper, 7 fuzzy) to 106 distinct CURIEs. Triage classified 77 well-characterized, 14 moderate, 14 sparse, and 1 cold-start, with 0 edge-count measurement failures. Downstream analysis produced 3415 direct-KG findings, 6 cold-start findings, 0 biological themes, 22 cross-entity bridges (20 evidence-grounded), and 28 hypotheses supported by 17 literature references. Synthesis emitted a 25648-character report. The run completed in approximately 1439.6 s of wall-clock time (status complete, 1 errors). All counts are taken from the reducer-merged pipeline state.

| Stage | Result |
|---|---|
| Submitted | 107 named analytes |
| Intake | 106 parsed |
| Entity resolution | 106 resolved (99 biomapper, 7 fuzzy) to 106 distinct CURIEs |
| Triage | 77 well-characterized, 14 moderate, 14 sparse, 1 cold-start (0 measurement failures) |
| Direct KG | 3415 findings |
| Cold-start | 6 findings, 9 skipped |
| Pathway enrichment | 0 biological themes |
| Integration | 22 bridges (20 evidence-grounded) |
| Literature grounding | 17 papers |
| Synthesis | 28 hypotheses, 25648-character report |
| Run total | ~1439.6 s wall-clock, status complete, 1 errors |

## Related

- Companion run metrics: [Turquoise Module Run: Pipeline Performance Report](https://phwiki.phenoma.ai/doc/turquoise-module-run-pipeline-performance-report-107-analyte-dev-2026-06-23-HE1isJ8kuw)
- [BioMapper: Collection Index](https://phwiki.phenoma.ai/doc/biomapper-collection-index-UcTfYSTchm)

---



## Turquoise WGCNA Module: Vascular Remodeling, Inflammatory Chemokine Signaling, and Metabolic Stress Integration

---

### 1. Executive Summary

This Turquoise WGCNA module encodes a coordinated program of vascular stabilization, chemokine-driven immune trafficking, and oxidative/metabolic stress defense, unifying 60 proteins and 46 metabolites whose co-expression converges on endothelial homeostasis and tissue remodeling rather than acute inflammatory initiation. [KG Evidence] The module's disease recurrence profile implicates inflammatory barrier disorders (asthma, psoriasis, gastroesophageal reflux) and cardiovascular pathology (essential hypertension, coronary artery disease), while its pathway architecture reveals enrichment for PI3K/AKT signaling, MAPK cascades, and stress response programs shared across 20 or more members. [KG Evidence] The accompanying metabolite signature (sphingolipids, purine intermediates, taurine/cysteine axis, TCA cycle intermediates) reinforces a model in which vascular endothelial and platelet-derived signals integrate with intracellular redox and one-carbon metabolism to maintain tissue integrity under chronic stress. [Inferred]

---

### 2. Key Findings (Tier 1 to 2)

#### 2.1 Disease Associations with Strong Recurrence

The module-level disease recurrence analysis reveals a striking convergence on inflammatory mucosal and barrier diseases. [KG Evidence]

| Disease | Members | Evidence |
|---|---|---|
| Gastroesophageal reflux disease | 21 | curated |
| Necrotizing ulcerative gingivitis | 21 | curated |
| Gastroduodenitis | 21 | curated |
| Asthma | 21 | curated |
| Panniculitis | 21 | curated |
| Psoriasis | 20 | curated |
| Irritable bowel syndrome | 20 | curated |
| Essential hypertension | 20 | curated |
| Coronary artery disorder | 17 | curated |

These associations share a common biological substrate: disrupted epithelial/endothelial barrier integrity accompanied by chemokine-mediated leukocyte infiltration. [KG Evidence] The recurrence of 20 to 21 module members across gastrointestinal, respiratory, and dermatologic barrier diseases indicates that the module captures a generalized mucosal-vascular inflammatory axis. [Inferred] Cardiovascular disorders (essential hypertension, coronary artery disease, hypertensive heart and renal disease) constitute a second disease cluster, consistent with the module's vascular endothelial gene content (VWF, PECAM1, ANGPT1, SELP, F2R). [KG Evidence]

Notably, progressive supranuclear palsy (16 members) and schizophrenia (11 members) represent neurological/neuropsychiatric associations that merit attention; both conditions involve neuroinflammatory and neurovascular components that align with this module's vascular-inflammatory character. [KG Evidence]

#### 2.2 Validated Pathway Memberships

The module-level pathway recurrence identifies the following biological processes as convergence points [KG Evidence]:

**Vascular and Growth Factor Signaling:**
- Positive regulation of PI3K/AKT signaling (8 members: HBEGF, F2R, ANGPT1, PDGFB, PECAM1, SELP, SRC, THPO) [KG Evidence]
- Positive regulation of ERK1/ERK2 cascade (4 members: ANGPT1, PDGFB, CCL17, THPO) [KG Evidence]
- Positive regulation of MAPK cascade (4 members: F2R, PDGFB, PECAM1, THPO) [KG Evidence]
- Angiogenesis (4 members: ANGPT1, CXCL1, PDGFB, PECAM1) [KG Evidence]

**Immune and Inflammatory Signaling:**
- Inflammatory response (9 members: F2R, IL17RA, CXCL1, CCL17, CXCL11, SELP, BMP6, TNFRSF14, CD40LG) [KG Evidence]
- Leukocyte migration (6 members: CXCL1, CCL17, CXCL11, SELP, SRC, CD84) [KG Evidence]
- Immune system process (6 members: PARP1, IL17RA, SELP, SRC, TNFRSF14, CD84) [KG Evidence]
- Cytokine-cytokine receptor interaction (WikiPathways WP5473; 5 members: IL17RA, CXCL1, CXCL11, TNFRSF14, CD40LG) [KG Evidence]

**Stress Response and Cell Fate:**
- Response to stress (21 members) [KG Evidence]
- Negative regulation of apoptotic process (7 members: DKK1, GLO1, ANGPT1, HSPB1, SOD2, SRC, CD40LG) [KG Evidence]
- Response to lipopolysaccharide (5 members: F2R, SELP, SOD2, THPO, CASP3) [KG Evidence]

#### 2.3 High-Priority Individual Members

The Member Prioritization Table identifies several entities with outsized biological leverage in this module [KG Evidence]:

- **PARP1** (10,000 edges; hub-flagged): Associated with ovarian cancer; participates in DNA repair, NF-kB co-activation, and chromatin remodeling. Its hub status warrants caution in interpreting associations, yet its co-expression with STK4 and IKBKG suggests a non-apoptotic, NF-kB-regulatory role in this module. [KG Evidence; Inferred]
- **ANGPT1** (2,286 edges): Associated with angioedema; canonical vessel maturation factor. Its co-expression with PDGFB, PECAM1, and VWF establishes the vascular stabilization core of this module. [KG Evidence]
- **SORT1** (2,738 edges): GWAS-identified regulator of LDL cholesterol; its presence in this module, absent lipid markers, suggests a neurotrophin-sorting or lysosomal trafficking function rather than its canonical lipid-regulatory role. [KG Evidence; Inferred]
- **TGM2** (3,325 edges): Associated with celiac disease; tissue transglutaminase functions in extracellular matrix cross-linking, reinforcing the module's matrix stabilization phenotype. [KG Evidence]
- **DECR1** (4,154 edges): Associated with progressive encephalopathy with leukodystrophy; this mitochondrial fatty acid beta-oxidation enzyme connects the module's metabolic component to its neurological disease associations. [KG Evidence]

#### 2.4 Cross-Type Bridges

Multiple two-hop knowledge graph paths connect the module's protein and metabolite components through shared disease and compartment nodes [KG Evidence]:

- PDGFB connects to spermidine via obesity disorder (clinical trial association), cardiovascular disorder, and cognitive impairment. [KG Evidence]
- DKK1 connects to spermidine via progesterone (interaction) and shared ontological classifications. [KG Evidence]
- PDGFB connects to adenosine 5'-monophosphate (AMP) via epilepsy, obesity disorder, cancer, and migraine disorder. [KG Evidence]

These bridges are biologically plausible: spermidine is an autophagy inducer with established cardioprotective effects [Literature: "Non-Linear Association of Dietary Polyamines with the Risk of Incident Dementia," 2024], and AMP is a central energy-sensing metabolite whose accumulation activates AMPK, a master regulator of metabolic homeostasis. [Model Knowledge]

---

### 3. Novel Predictions (Tier 3)

#### 3.1 Non-Canonical Inflammatory Axis Driven by Chemokines Rather Than Classical Cytokines

**Prediction:** This module encodes a chemokine-dominant inflammatory program (CXCL1, CXCL5, CXCL6, CXCL11, CCL8, CCL13, CCL17, CCL28) that operates independently of classical IL-6/TNF-mediated acute-phase inflammation.

**Structural logic chain:** The module contains eight chemokines and their receptor IL17RA, plus endothelial adhesion molecules (SELP, PECAM1, VWF, F11R) and damage signals (HBEGF), but lacks IL-6 and TNF. [KG Evidence] The gap analysis identifies the absence of IL-6 and TNF as informative: this module captures downstream effector responses (leukocyte trafficking, endothelial activation) rather than initiating cytokine signals. [KG Evidence] The co-expression of CD40/CD40LG (costimulatory pair) with TNFRSF14 and TNFSF12/TNFSF14 (TNF superfamily ligands/receptors) suggests that adaptive immune costimulation, not innate cytokine storms, drives the inflammatory component. [Inferred]

**Validation step:** Measure IL-6 and TNF protein levels in the study samples to confirm their partition into separate WGCNA modules; perform conditional correlation analysis to test whether the chemokine cluster correlates with tissue-specific leukocyte infiltration markers independently of systemic IL-6.

**Calibration:** Approximately 18% of such computational predictions progress to clinical investigation.

#### 3.2 VEGF-Independent Vascular Stabilization Program

**Prediction:** The module represents a vessel maturation and stabilization program mediated by ANGPT1/PDGFB/THPO, operating independently of VEGFA-driven sprouting angiogenesis.

**Structural logic chain:** ANGPT1, PDGFB, PECAM1, and VWF are established mediators of vascular stabilization and pericyte recruitment. [KG Evidence] The pathway recurrence confirms their shared participation in angiogenesis (4 members), PI3K/AKT signaling (8 members), and positive regulation of cell migration (4 members). [KG Evidence] VEGFA is expected as a canonical partner of ANGPT1 but is absent from this module. [KG Evidence: gap analysis] The informative absence of VEGFA, combined with the absence of MMP9 (matrix degradation), indicates a pro-stabilization rather than pro-angiogenic phenotype: ANGPT1 promotes vessel maturation by recruiting pericytes (via PDGFB), while TGM2 cross-links the extracellular matrix to prevent vascular leakage. [Model Knowledge; Inferred]

**Validation step:** Perform immunohistochemical co-localization of ANGPT1, PDGFB, and TGM2 in vascular tissue from study participants; quantify pericyte coverage (NG2/PDGFRB staining) to confirm vessel maturation rather than sprouting angiogenesis.

**Calibration:** Approximately 18% of such computational predictions progress to clinical investigation.

#### 3.3 Sphingolipid-Vascular Endothelial Signaling Axis

**Prediction:** The co-expression of sphingolipid metabolites (sphingosine, sphinganine, sphingosine 1-phosphate, sphinganine-1-phosphate) with vascular endothelial proteins (PECAM1, VWF, SELP, ANGPT1) reflects a functional sphingosine 1-phosphate (S1P) signaling axis that regulates endothelial barrier integrity.

**Structural logic chain:** Sphingosine 1-phosphate (S1P; 364 edges) and its biosynthetic precursors sphingosine (922 edges) and sphinganine (418 edges) are present alongside their reduced forms (sphinganine-1-phosphate, 113 edges). [KG Evidence] S1P signals through S1PR1-5 receptors on endothelial cells to regulate vascular permeability, leukocyte egress, and angiogenesis. [Model Knowledge] The module's endothelial adhesion molecules (PECAM1, SELP, VWF) and platelet-derived factors (GP6, THPO, serotonin) suggest a platelet-endothelial interface where S1P, released from activated platelets, reinforces endothelial barrier function. [Inferred] Phosphoethanolamine (4,442 edges), glycerophosphoethanolamine, and choline phosphate further support active phospholipid metabolism at this interface. [KG Evidence]

**Validation step:** Correlate plasma S1P levels with PECAM1 and VWF protein concentrations in the study cohort; test whether S1P receptor antagonism (e.g., fingolimod) disrupts the co-expression pattern in an in vitro endothelial model.

**Calibration:** Approximately 18% of such computational predictions progress to clinical investigation.

#### 3.4 Integrated Oxidative Stress and One-Carbon/Sulfur Amino Acid Metabolism

**Prediction:** The co-expression of oxidative stress defense proteins (SOD2, GLO1) with sulfur-containing metabolites (taurine, hypotaurine, cysteine) and redox cofactors (FAD, nicotinamide, succinate) reflects a coordinated cytoprotective program linking mitochondrial ROS scavenging to transsulfuration pathway flux.

**Structural logic chain:** SOD2 (mitochondrial superoxide dismutase; 2,370 edges) and GLO1 (glyoxalase 1; 2,931 edges) participate in the response to stress pathway (21 members) and negative regulation of apoptotic process (7 members). [KG Evidence] Cysteine (2,495 edges) is the rate-limiting precursor for glutathione synthesis and a substrate for the transsulfuration pathway that produces taurine via hypotaurine. [Model Knowledge] The presence of both taurine (1,612 edges) and hypotaurine (91 edges) indicates active flux through this pathway. [Inferred] FAD (1,313 edges) serves as cofactor for glutathione reductase and succinate dehydrogenase, while nicotinamide (2,991 edges) feeds NAD+ biosynthesis for PARP1 and SIRT2 enzymatic activity. [Model Knowledge] Succinate (2,218 edges), as a TCA cycle intermediate, may indicate mitochondrial metabolic stress or succinate receptor (SUCNR1) signaling in inflammatory contexts. [Inferred]

**Validation step:** Measure glutathione (GSH/GSSG ratio) and NAD+/NADH ratios in study samples; perform Mendelian randomization using SOD2 and GLO1 eQTL instruments to test for causal effects on taurine and cysteine levels.

**Calibration:** Approximately 18% of such computational predictions progress to clinical investigation.

#### 3.5 DKK1 as a Constitutive Wnt Antagonist in Vascular Remodeling

**Prediction:** DKK1 functions in this module as a tonic Wnt inhibitor that promotes vascular identity over osteogenic differentiation, operating independently of acute Wnt ligand modulation.

**Structural logic chain:** DKK1 participates in negative regulation of canonical Wnt signaling (direct KG evidence), negative regulation of BMP signaling pathway, and negative regulation of SMAD protein signal transduction. [KG Evidence] DKK1 interacts with LRP5, LRP6, KREMEN1, and KREMEN2 (Tier 2 interactions). [KG Evidence] The gap analysis identifies the absence of WNT3A and WNT5A as informative: DKK1 may be constitutively expressed to suppress Wnt-driven osteogenic programs in vascular tissue, preventing vascular calcification. [KG Evidence: gap analysis] Literature evidence confirms that DKK1 is induced in neuronal cultures as a stress response and drives synapse loss through effects on Wnt signaling. [Literature: "A role for APP in Wnt signalling links synapse loss with β-amyloid production," 2018] The co-expression of DKK1 with BMP6 (which promotes iron homeostasis via hepcidin rather than osteogenesis in this context) and AXIN1 (a negative regulator of Wnt/beta-catenin) reinforces a model of coordinated Wnt suppression. [Inferred]

**Validation step:** Quantify Wnt pathway activity (nuclear beta-catenin, TCF/LEF reporter) in vascular cells from study participants; test whether DKK1 knockdown induces osteogenic markers (RUNX2, alkaline phosphatase) or alters ANGPT1/PDGFB expression.

**Calibration:** Approximately 18% of such computational predictions progress to clinical investigation.

---

### 4. Biological Themes

#### 4.1 Vascular Endothelial Homeostasis and Platelet Interface

The dominant biological theme of this module is the maintenance of vascular endothelial integrity through a coordinated ensemble of vessel-stabilizing growth factors (ANGPT1, PDGFA, PDGFB), endothelial adhesion molecules (PECAM1, VWF, SELP, F11R), platelet activation receptors (GP6, F2R, THPO), and sphingolipid signaling intermediates (S1P, sphingosine, sphinganine). [KG Evidence; Inferred] The pathway recurrence confirms enrichment for angiogenesis (4 members), PI3K/AKT signaling (8 members), and positive regulation of cell migration (4 members). [KG Evidence]

Hub-filtered interpretation: SRC (10,000 edges; hub-flagged) and CASP3 (10,000 edges; hub-flagged) participate in many of these pathways, but their extreme connectivity renders specific associations unreliable. [KG Evidence] The vascular theme remains robust when these hubs are excluded, as ANGPT1, PDGFB, PECAM1, VWF, and SELP independently support it. [Inferred]

#### 4.2 Chemokine-Mediated Immune Cell Trafficking

The module contains a dense chemokine cluster spanning CXC chemokines (CXCL1, CXCL5, CXCL6, CXCL11) and CC chemokines (CCL8, CCL13, CCL17, CCL28), complemented by the IL-17 receptor subunit IL17RA, TNF superfamily members (TNFSF12, TNFSF14, TNFRSF14), and costimulatory molecules (CD40, CD40LG). [KG Evidence] The pathway enrichment for leukocyte migration (6 members), inflammatory response (9 members), and immune response (8 members) confirms that immune cell recruitment and activation represent a core module function. [KG Evidence] CD8A and CD244 suggest a cytotoxic T-cell and NK-cell component to this trafficking program. [Inferred]

#### 4.3 Stress Defense and Metabolic Sensing

The module integrates oxidative stress defense (SOD2, GLO1, HSPB1), DNA damage sensing (PARP1), deacetylation-based stress signaling (SIRT2), and apoptotic regulation (STK4, CASP8) with metabolic intermediates that report on cellular energetic and redox status. [KG Evidence; Inferred] Succinate, AMP, cAMP, FAD, and nicotinamide collectively represent nodes in the TCA cycle, purine salvage, and NAD+ metabolism. [Model Knowledge] The co-expression of these metabolites with their enzymatic consumers (PARP1 consumes NAD+; SIRT2 consumes NAD+; SOD2 requires manganese cofactor) suggests coordinated regulation of metabolic flux under stress conditions. [Inferred]

#### 4.4 Pyrimidine and Nucleotide Metabolism

The presence of orotate, dihydroorotate, uracil, and modified nucleosides (3-methylcytidine, 2'-O-methylcytidine) indicates active de novo pyrimidine synthesis and RNA modification. [KG Evidence] Orotate and dihydroorotate are sequential intermediates in the de novo pyrimidine pathway catalyzed by DHODH (mitochondrial) and UMPS. [Model Knowledge] Their co-expression with purine metabolites (AMP, cAMP, inosine) suggests a broader nucleotide biosynthetic program, potentially driven by proliferating immune or endothelial cells within the module's functional context. [Inferred]

---

### 5. Gap Analysis

#### 5.1 Informative Absences

The gap analysis, conducted under the Open World Assumption (absence indicates "unstudied," not "nonexistent"), reveals several biologically meaningful absences [KG Evidence]:

**IL-6 and TNF:** The absence of these canonical pro-inflammatory cytokines from a module containing 8 chemokines, CD40/CD40LG, and multiple TNF superfamily members is informative. The module likely captures a downstream effector inflammatory program (leukocyte homing, endothelial activation) rather than the initiating cytokine cascade. [KG Evidence]

**VEGFA:** The presence of ANGPT1 and PDGFB without VEGFA distinguishes this module from canonical sprouting angiogenesis programs. The module encodes vessel stabilization and maturation. [KG Evidence]

**MMP9:** The absence of matrix metalloproteinase 9, together with the presence of TGM2 (matrix cross-linker), indicates a matrix-stabilizing rather than matrix-degrading phenotype. [KG Evidence]

**TP53 and CASP3 (as gap entity):** The gap analysis initially flagged CASP3 as expected-but-absent; however, CASP3 is present in the module (10,000 edges, hub-flagged). This discrepancy likely reflects the gap analysis operating on a subset of entities. [Inferred] TP53 is genuinely absent, suggesting that PARP1 and STK4 operate in p53-independent contexts: PARP1 in NF-kB co-activation and chromatin remodeling, STK4 in oxidative stress sensing via the MST1-FOXO axis. [KG Evidence]

**WNT3A/WNT5A:** DKK1 (Wnt antagonist) and AXIN1 (Wnt pathway scaffold/negative regulator) are present without Wnt ligand co-expression partners. DKK1 interacts with WNT3A, WNT5B, WNT7A, WNT7B, WNT8A, WNT9A, WNT10A, and others at Tier 2. [KG Evidence] The absence of these ligands from the co-expression module suggests that DKK1's function here is constitutive Wnt suppression rather than dynamic Wnt pathway modulation. [Inferred]

**NFE2L2 (NRF2) and HMOX1:** The absence of these master antioxidant regulators despite the presence of their downstream targets (SOD2, GLO1) may reflect post-translational regulation of NRF2 (KEAP1-mediated degradation) or assay platform limitations. [KG Evidence]

#### 5.2 Cold-Start and Low-Coverage Entities

Gamma-glutamylcitrulline has no knowledge graph presence (0 edges), representing a true cold-start entity. [KG Evidence] Semantic similarity analysis identified gamma-glutamylcitrulline as 100% similar to its own resolved analogue (RM:0156813), but no disease or pathway associations could be retrieved. [KG Evidence] Several plasmalogen species (1-(1-enyl-palmitoyl)-GPE, 1-(1-enyl-stearoyl)-GPE, 1-(1-enyl-oleoyl)-GPE) have sparse KG coverage (1 to 38 edges) and were resolved with low confidence (70% fuzzy match). [KG Evidence] These entities require manual curation before biological interpretation.

EDTA (1,963 edges) is likely an artifact of sample collection (chelating agent in blood collection tubes) rather than a biologically meaningful analyte. [Model Knowledge]

---

### 6. Temporal Context

No longitudinal design information was provided with this analysis. Temporal interpretation must therefore be inferred from biological directionality rather than measured time-course data. [Model Knowledge]

**Upstream causes (predicted):** Growth factor signaling (PDGFB, ANGPT1, HBEGF, BMP6), costimulatory activation (CD40/CD40LG), and metabolic stress (reflected in AMP, succinate, FAD accumulation) likely represent upstream triggers of the module. [Inferred]

**Downstream consequences (predicted):** Chemokine secretion (CXCL1, CXCL5, CXCL6, CXCL11, CCL8, CCL13, CCL17, CCL28), endothelial adhesion molecule upregulation (SELP, PECAM1, VWF), extracellular matrix remodeling (TGM2, SERPINE1, PLAT), and apoptotic regulation (CASP3, CASP8, STK4) represent effector outputs. [Inferred]

**Causal inference opportunity:** Mendelian randomization using GWAS instruments for SORT1 (lipid regulation), ANGPT1 (vascular phenotypes), and PECAM1 (cardiovascular traits) could establish causal direction between the vascular and inflammatory components. [Inferred]

---

### 7. Research Recommendations

#### Priority 1: Experimental Validations

1. **Sphingolipid-endothelial axis:** Correlate plasma sphingosine 1-phosphate concentrations with circulating PECAM1, VWF, and SELP levels in the study cohort to test the predicted S1P-vascular signaling connection. [Inferred]

2. **Chemokine dominance over classical cytokines:** Measure IL-6 and TNF protein levels in the same samples to confirm their segregation from this module; perform partial correlation analysis controlling for IL-6/TNF to assess whether the chemokine cluster operates independently. [Inferred]

3. **DKK1-vascular calcification hypothesis:** Test whether plasma DKK1 levels inversely correlate with coronary artery calcium scores in the study population, consistent with a Wnt-suppressive, anti-calcification role. [Inferred]

#### Priority 2: Literature Searches for Emerging Connections

4. **Spermidine-cardiovascular protection:** The knowledge graph bridges connecting PDGFB to spermidine via cardiovascular disorder and cognitive impairment align with emerging literature on spermidine as a cardioprotective autophagy inducer. [Literature: "Non-Linear Association of Dietary Polyamines with the Risk of Incident Dementia," 2024] A systematic review of spermidine supplementation trials in cardiovascular and neurocognitive endpoints is warranted. [Inferred]

5. **2-Hydroxyglutarate as an oncometabolite:** 2-Hydroxyglutarate (108 edges) is an established oncometabolite produced by mutant IDH1/2 enzymes. [Model Knowledge] Its co-expression in this module should be evaluated for association with IDH mutation status if relevant clinical data are available. [Inferred]

6. **Beta-citrylglutamate and sarcosine:** These metabolites (12 and 494 edges, respectively) have emerging roles as neuronal markers and prostate cancer biomarkers, respectively. [Model Knowledge] Their co-expression with this vascular-inflammatory module is unexpected and warrants targeted literature review. [Inferred]

#### Priority 3: Follow-Up Analyses

7. **Module preservation analysis:** Test whether the Turquoise module is preserved in independent cohorts (e.g., GTEx vascular tissues, cardiovascular disease case-control studies) to assess generalizability. [Inferred]

8. **Hub gene removal sensitivity:** Repeat WGCNA after excluding hub-flagged entities (PARP1, SRC, CASP3, MMP1, TGFB1, HSPB1, CD40, EIF4EBP1, CASP8, AMP) to determine whether the module's structure is robust to hub bias. [KG Evidence]

9. **Metabolite pathway enrichment:** Perform formal metabolite set enrichment analysis (MSEA) on the 46 metabolites using MetaboAnalyst to quantify enrichment for sphingolipid metabolism, pyrimidine biosynthesis, and transsulfuration pathways. [Inferred]

10. **Cold-start entity curation:** Manually curate the identity and biological function of gamma-glutamylcitrulline, the plasmalogen species (P-16:0, P-18:0, P-18:1), and EDTA (likely artifact) before integrating them into downstream analyses. [KG Evidence]

---

*Report generated from KRAKEN knowledge graph analysis. All factual claims are tagged with evidence source: [KG Evidence], [Literature], [Model Knowledge], or [Inferred]. Tier 3 predictions carry the standard calibration that approximately 18% of computational predictions progress to clinical investigation.*

### Literature References

Papers discovered via semantic search. 2 unique papers across 3 hypotheses.

| Hypothesis | Citation | Link | Relevance |
|------------|----------|------|-----------|
| Bridge: Gene → Protein (2 hops) |  (2018) "A role for APP in Wnt signalling links synapse loss with β-amyloid production \| Translational Psychi..." | [Link](https://www.nature.com/articles/s41398-018-0231-6) | 10, ... 11, ... kopf-1 ( ... models of A ... 1, and ... is induced in neuronally ... cultures as an ... response to Aβ .... |
| Bridge: Gene → ChemicalEntity (2 hops); Bridge: Gene → SmallMolecule (2 hops) |  (2022) "Frontiers \| Most Pathways Can Be Related to the Pathogenesis of Alzheimer's Disease" | [Link](https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2022.846902/full) | Kyoto Encyclopedia of ... ) pathways have publications containing ... association via at ... 63 ... of pathway terms hav... |